COMMUNITY TRUST BANCORP INC /KY/ Stock Compensation Disclosure
|
Plan Category (shares in thousands)
|
Number of
Shares to Be
Issued Upon
Exercise
|
Weighted
Average Price
|
Shares
Available for
Future Issuance
|
|||||||||
|
Equity compensation plans approved by shareholders:
|
||||||||||||
|
Stock options
|
0
|
|
0
|
550
|
(a)
|
|||||||
|
Restricted stock
|
(c)
|
(b)
|
(a)
|
|||||||||
|
Performance units
|
(d)
|
(b)
|
(a)
|
|||||||||
|
Stock appreciation rights (“SARs”)
|
(e)
|
(b)
|
(a)
|
|||||||||
|
Total
|
550
|
|||||||||||
| (a) |
Under the 2025 Plan, 550,000 shares are authorized for issuance; no
shares have been issued as of December 31, 2025. The maximum number of stock options that may be granted to a participant during any calendar year is 100,000 shares.
|
| (b) |
Not applicable.
|
| (c) |
The maximum number of
shares of restricted stock that may be granted is 550,000 shares, and the maximum that may be granted to a participant during
any calendar year is 75,000 shares.
|
| (d) |
No performance units payable in stock had been issued as of December 31, 2024. The maximum payment that can be made pursuant to performance units granted to any one participant in any calendar year is $1,000,000.
|
| (e) |
No SARS have been issued. The maximum number of shares with respect to which SARs may be granted to a participant during any calendar year is 100,000 shares.
|
|
December 31
|
2025
|
2024
|
2023
|
|||||||||||||||||||||
|
Grants
|
Weighted
Average
Fair
Value at
Grant
|
Grants
|
Weighted
Average
Fair
Value at
Grant
|
Grants
|
Weighted
Average
Fair
Value at
Grant
|
|||||||||||||||||||
|
Outstanding at beginning of year
|
86,572
|
$
|
43.45
|
96,840
|
$
|
43.75
|
68,137
|
$
|
44.13
|
|||||||||||||||
|
Granted
|
38,538
|
53.53
|
15,000
|
41.29
|
52,865
|
43.10
|
||||||||||||||||||
|
Vested
|
(29,057
|
)
|
44.26
|
(22,831
|
)
|
43.37
|
(23,372
|
)
|
43.32
|
|||||||||||||||
|
Forfeited
|
(5,877
|
)
|
47.00
|
(2,437
|
)
|
42.87
|
(790
|
)
|
44.87
|
|||||||||||||||
|
Outstanding at end of year
|
90,176
|
$ |
47.27
|
86,572
|
$
|
43.45
|
96,840
|
$
|
43.75
|
|||||||||||||||
|
December 31
|
2024
|
2023
|
||||||||||||||
|
Options
|
Weighted
Average
Exercise
Price
|
Options
|
Weighted
Average
Exercise
Price
|
|||||||||||||
|
Outstanding at beginning of year
|
20,000
|
$
|
32.27
|
20,000
|
$
|
32.27
|
||||||||||
|
Exercised
|
20,000
|
32.27
|
0
|
0
|
||||||||||||
|
Outstanding at end of year
|
0
|
$
|
0.00
|
20,000
|
$
|
32.27
|
||||||||||
|
Exercisable at end of year
|
0
|
$
|
0.00
|
20,000
|
$
|
32.27
|
||||||||||
|
(in thousands)
|
2024
|
2023
|
||||||
|
Options exercised
|
$
|
335
|
$
|
0
|
||||
|
Options exercisable
|
0
|
232
|
||||||
|
Outstanding options
|
0
|
232
|
||||||
|
(in thousands)
|
2025
|
2024
|
2023
|
|||||||||
|
Unrecognized compensation cost of nonvested share-based compensation arrangements granted under the plan at year-end
|
$
|
2,475
|
$
|
2,277
|
$
|
2,954
|
||||||
|
Total fair value of shares vested for the year
|
1,546
|
954
|
974
|
|||||||||
|
Cash received from option exercises under all share-based payment arrangements for the year
|
0
|
645
|
0
|
|||||||||
|
Tax benefit realized for the tax deductions from option exercises of the share-based payment arrangements for the year
|
0
|
84
|
0
|
|||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 27, 2026 | Showing above |
| 2024 | Feb 28, 2025 | |
| 2023 | Feb 28, 2024 | |
| 2022 | Feb 28, 2023 | |
| 2021 | Feb 28, 2022 | |
About Stock Compensation Disclosures
Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.
Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.